Authors:
Monali Tayade, Sampada Kulkarni
Download free PDF
U.S. Telemedicine Market Size & Share 2026-2035
Report ID: GMI4362
|
Published Date: October 2026
|
Report Format: PDF/Excel/Dashboard/Platform
Explore Our Licensing Options:
U.S. Telemedicine Market
Get a free sample of this report
What are you hoping to find?
Your PDF is on its way. Tell us little about your research goal, and we'll help you find the most relevant market insights.
U.S. Telemedicine Market Size
The U.S. telemedicine market was valued at USD 35.9 billion in 2025, is expected to reach USD 41.64 billion in 2026, and is projected to grow at a 16% CAGR (2025–2035) to reach USD 155.93 billion by 2035. The market covers technology-enabled healthcare delivery across real-time consultations, remote patient monitoring, asynchronous care, and integrated digital platforms serving providers, payers, and patients.
U.S. Telemedicine Market Key Takeaways
Market Leader: Teladoc Health led with over 5.8% market share in 2025.
Leading Players: Top 5 players in this market include Teladoc Health, Amwell, Oracle Health, GE Healthcare, Philips, which collectively held a market share of 45% in 2025.
Growth is being shaped by the operational integration of virtual care into clinical workflows rather than by a temporary utilization surge. Provider organizations are using telemedicine to extend specialty capacity, manage chronic conditions between in-person encounters, and support distributed care models, while payers are incorporating virtual access into benefit design, network strategy, and utilization management.
GMI Analyst View
Based on our ongoing engagement with market participants and primary research across the U.S. healthcare ecosystem, U.S. telemedicine market revenue reached USD 30.78 billion in 2024. We view this as evidence that the market had already progressed beyond pandemic-era experimentation before the 2025 base year, shifting competitive emphasis toward measurable clinical performance, payer integration, and durable specialty-care workflows.
U.S. Telemedicine Market Trends, Growth Drivers & GMI Forecast Outlook
The market outlook rests on a widening mismatch between clinical demand and conventional care capacity. Behavioral health access constraints, reimbursement-supported platform adoption, and more efficient digital workflows are expanding demand, while cybersecurity obligations, infrastructure gaps, and reimbursement ambiguity continue to determine where and how quickly deployment can scale.
Key Drivers
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Behavioral health is a particularly durable demand channel because virtual delivery can address both provider scarcity and the practical barriers that delay treatment, including travel, scheduling, and fragmented local networks. Tele-psychiatry vendors are therefore competing not simply for visit volume, but for placement within payer networks, employer benefits, and provider referral pathways where clinical capacity is a constrained asset.
Medicare participation provides an important commercial floor for health systems and platform vendors making multi-year investments in virtual care infrastructure. Once reimbursement is sufficiently dependable, procurement decisions can shift from isolated video-visit programs toward integrated workflows that connect scheduling, documentation, patient engagement, and monitoring across specialty service lines.
AI integration is also changing the economics of platform deployment. Documentation assistance, triage tools, and asynchronous clinical workflows can reduce administrative friction around each encounter, improving the viability of virtual models in lower-acuity settings where direct clinical time and support costs would otherwise limit adoption.
Key Restraints
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Cybersecurity has become a commercial qualification issue as much as a technical one. Large providers and health plans increasingly expect vendors to meet demanding security, audit, interoperability, and incident-response requirements before virtual-care programs can move beyond pilots. These obligations favor vendors with established compliance infrastructure and can lengthen sales cycles for smaller specialists.
Broadband limitations create a different constraint: they reduce the practical reach of synchronous care precisely where specialty access needs may be most acute. Audio-first care models can partly mitigate this barrier, but remote monitoring, high-quality video, and data-intensive workflows require connectivity conditions that remain uneven across rural communities.
GMI Analyst View
We expect market development to favor platforms that can combine clinical operations, security controls, analytics, and reimbursement-aware workflows rather than offering video access as a stand-alone service. The principal restraints are likely to shape the timing and channel mix of expansion, not reverse the underlying shift toward digitally coordinated care.
U.S. Telemedicine Market Segment Analysis
By Component
Hardware
The U.S. telemedicine market hardware segment generated USD 7.18 billion in 2025 and is projected to grow at a 14.5% CAGR (2025–2035). Connected diagnostic peripherals, home-monitoring devices, and clinical communication equipment remain essential to care models that require physiological data or specialist oversight beyond a conventional virtual consultation.
Hardware demand is increasingly tied to the design of chronic-care and post-acute programs. Vendors that can connect devices reliably into clinical workflows, rather than merely supply equipment, are better positioned to participate in recurring remote patient management contracts.
Software — Cloud-based
Cloud-based software accounted for 27% of the market in 2025 and is projected to grow at an 18.2% CAGR (2025–2035). Its scale reflects demand for interoperable, multi-site platforms that can support payer programs, provider networks, and distributed clinical teams without the operational burden of locally managed infrastructure.
The segment benefits from the need to coordinate scheduling, documentation, patient communication, and data exchange across care settings. Cloud architectures are particularly relevant where organizations want to standardize virtual-care delivery across multiple specialties and geographies.
Software — On-premises
On-premises software generated USD 2.87 billion in 2025 and is projected to grow at a 9.0% CAGR (2025–2035). The segment remains relevant in organizations with restrictive governance requirements, established clinical technology estates, or deployment preferences that limit migration to externally hosted environments.
Its slower trajectory reflects the trade-off between data-control priorities and the flexibility required for fast feature deployment. Renewal revenue and institutional integration can preserve demand, but the strategic center of gravity is moving toward platforms that can scale across networks more readily.
Services — Tele-consultation
Tele-consultation represented 22% of the market in 2025 and is projected to grow at a 16.5% CAGR (2025–2035). It remains the foundational service modality for behavioral health, urgent care, follow-up care, and specialty access, where clinician availability and patient convenience directly influence utilization.
Competitive performance depends on provider-network depth, wait-time management, clinical quality, and reimbursement alignment. As virtual visits become a routine care option, service differentiation is moving from basic access toward specialty appropriateness and continuity with in-person care.
Services — Tele-monitoring
Tele-monitoring generated USD 4.67 billion in 2025 and is projected to grow at an 18.0% CAGR (2025–2035). Demand is being supported by chronic-condition programs that require ongoing visibility into patient status between office visits, particularly where avoidable escalation or hospitalization carries significant clinical and financial consequences.
The segment's appeal lies in its ability to connect device data, clinical review, and patient outreach in a single operating model. Better alert prioritization and workflow integration can make monitoring programs more scalable for providers and more actionable for payers.
Services — Tele-education & Training
Tele-education and training accounted for 5% of the market in 2025 and is projected to grow at a 14.0% CAGR (2025–2035). The segment supports clinical onboarding, workforce development, patient education, and adoption of new digital-care workflows across provider organizations.
Its expansion is linked to implementation intensity. As telemedicine platforms become embedded in more care settings, health systems and specialty practices need repeatable methods to train clinicians, support staff, and patients without disrupting care delivery.
By Specialty Area
Psychiatry
Psychiatry generated USD 7.90 billion in 2025 and is projected to grow at an 18.5% CAGR (2025–2035). The specialty benefits from a structural mismatch between mental health demand and available licensed clinical capacity, making virtual delivery a practical route to expand access across payer, employer, and provider channels.
The segment's commercial strength is reinforced by the suitability of many psychiatric consultations for recurring remote engagement. Sustained growth will depend on provider recruitment, prescribing workflows, clinical governance, and the ability to integrate virtual behavioral health with broader care-management programs.
Cardiology
Cardiology generated USD 6.46 billion in 2025 and is projected to grow at a 16.8% CAGR (2025–2035). Remote oversight is increasingly relevant for patients requiring longitudinal monitoring, follow-up after procedures, and specialist access outside major cardiovascular centers.
The segment benefits from the interaction between specialist consultation and connected data streams. Tele-cardiology models become more valuable when they help clinical teams identify deterioration earlier, coordinate referrals, and manage high-risk patients across hospital and home settings.
Endocrinology
Endocrinology represented 10% of the market in 2025 and is projected to grow at a 17.2% CAGR (2025–2035). Diabetes management, connected monitoring, and preventive coaching make the specialty well suited to longitudinal virtual-care relationships.
The opportunity extends beyond individual consultations. Virtual endocrinology programs can link clinicians, educators, monitoring tools, and payer-sponsored population-health initiatives, giving the segment a role in both specialty access and chronic-disease management.
Oncology
Oncology accounted for 8% of the market in 2025 and is projected to grow at a 16.5% CAGR (2025–2035). Virtual services are increasingly used for navigation, symptom reporting, counseling, and follow-up between in-person treatment events.
Clinical value is strongest where telemedicine complements rather than replaces intensive care delivery. Programs that improve communication between treatment cycles and identify problems early can reduce avoidable patient burden while preserving specialist oversight.
Pulmonology
Pulmonology generated USD 2.87 billion in 2025 and is projected to grow at a 15.0% CAGR (2025–2035). Demand is supported by virtual follow-up and remote monitoring for patients with chronic respiratory conditions who need ongoing assessment but may have limited local access to specialists.
The segment's trajectory depends on reliable patient engagement and usable clinical data. Care models that translate home-based measures into timely clinical action are likely to be more durable than programs centered solely on remote device deployment.
Gastroenterology
Gastroenterology generated USD 2.51 billion in 2025 and is projected to grow at a 15.5% CAGR (2025–2035). Virtual consultations can improve referral triage, chronic-condition follow-up, and preparation for in-person diagnostic or procedural care.
The specialty's telemedicine model is particularly effective when it helps clinicians determine the appropriate next step before patients enter capacity-constrained procedural pathways. This can improve scheduling efficiency while preserving in-person resources for care that requires them.
Gynecology
Gynecology represented 6% of the market in 2025 and is projected to grow at a 14.8% CAGR (2025–2035). Virtual care aligns with patient needs in areas such as counseling, follow-up, reproductive health, and selected prenatal or postpartum interactions.
Privacy, convenience, and continuity make virtual delivery commercially relevant, but sustained adoption depends on how well platforms integrate with established women's-health practices and referral pathways for services requiring in-person examination or intervention.
Rheumatology
Rheumatology accounted for 5% of the market in 2025 and is projected to grow at a 14.2% CAGR (2025–2035). Chronic disease management and the need for periodic specialist follow-up create a practical basis for hybrid care models that combine virtual reviews with targeted in-person assessment.
Tele-rheumatology can be especially meaningful in areas with limited specialist density. Its value proposition centers on maintaining clinical continuity and reducing travel burden without compromising escalation pathways when symptoms require direct examination.
Other Specialties
Other specialties accounted for 16% of the market in 2025 and are projected to grow at a 14.0% CAGR (2025–2035). This grouping includes clinical disciplines where asynchronous review, specialist consultation, and institutional coverage models can extend access beyond traditional appointment-based care.
The diversity of these use cases means adoption will not be uniform. Specialties with clearly defined digital workflows, strong referral economics, or urgent access requirements are more likely to scale than those in which the virtual encounter adds limited clinical value.
By End Use
Healthcare Providers
Healthcare providers generated USD 19.75 billion in 2025 and are projected to grow at a 15.5% CAGR (2025–2035). Within this end-use group, Hospitals & Clinics generated USD 12.57 billion in 2025, while Long-term Care Centers generated USD 4.31 billion in 2025. The U.S. telemedicine market is being operationalized by providers through enterprise platforms, virtual specialty programs, post-discharge monitoring, and staffing models that connect care teams across sites.
Provider demand is shaped by the need to make virtual care clinically useful within existing operations. Adoption is strongest where telemedicine supports access, workforce coverage, readmission management, or continuity of care without creating parallel workflows that clinicians must manage separately.
Payers
Payers accounted for 20% of the market in 2025 and are projected to grow at a 17.2% CAGR (2025–2035). Their role is expanding from reimbursement administration toward active program design, network contracting, and member engagement through virtual-first and hybrid-care offerings.
Payer purchasing power increasingly influences platform requirements. Vendors must demonstrate clinical appropriateness, network quality, utilization-management value, and the ability to integrate virtual services into benefit structures that serve different member populations.
Patients
Patients generated USD 5.39 billion in 2025 and are projected to grow at an 18.5% CAGR (2025–2035). Direct spending, subscription models, and consumer-oriented access channels are broadening the patient-facing revenue base beyond conventional provider- or payer-sponsored encounters.
Consumer demand is likely to remain concentrated in care categories where access friction is high and the clinical interaction can be delivered safely online. However, long-term retention will depend on trust, affordability, care continuity, and credible escalation to in-person services when needed.
GMI Analyst View
We see the most consequential segment opportunity in platforms that unite specialty access with longitudinal data and recurring clinical engagement. Psychiatry, remote monitoring, and consumer-directed channels point to a market in which value is increasingly created through continuity of care and distribution reach, not through isolated virtual encounters.
U.S. Telemedicine Market Regional Analysis
United States Telemedicine Market Analysis
The United States telemedicine market generated USD 21.66 billion in 2022 and USD 25.76 billion in 2023. This progression reflected the continued normalization of virtual care across provider networks, payer programs, and specialty delivery models after the initial pandemic-driven expansion in use.
The U.S. operating environment remains highly consequential because reimbursement, privacy, clinical licensure, and broadband conditions vary across care settings and populations. National platforms must therefore balance the scale benefits of standardized technology with the local realities of provider credentialing, payer contracting, and connectivity.
Rural markets illustrate both the need for and the constraints on telemedicine. Behavioral health, specialty consultation, and chronic-disease management can address persistent access gaps, but adoption depends on infrastructure, local clinical workflows, and reimbursement arrangements that make virtual care practical for providers and patients.
GMI Analyst View
We believe the next phase of U.S. expansion will be determined by execution in underserved and operationally complex settings rather than by broad consumer awareness alone. Vendors that can support audio-capable pathways, safety-net providers, and Medicaid-oriented administrative requirements are likely to gain strategic relevance as the market broadens.
U.S. Telemedicine Market Share & Competitive Landscape
The U.S. telemedicine market share landscape remains fragmented because the market combines clinical service operators, enterprise software providers, remote-monitoring specialists, connected-device manufacturers, and healthcare workflow vendors. Competitive advantage depends on the ability to meet the distinct requirements of provider systems, payers, employers, and consumer channels while sustaining security, interoperability, and clinical quality.
Teladoc Health
Teladoc Health generated USD 2.07 billion in revenue in 2025 and held a 5.8% market share in 2025. Its position reflects a broad footprint spanning virtual consultations, behavioral health, chronic-condition support, and enterprise relationships with health plans and employers.
The company's strategic position is supported by its ability to combine member access, clinical-service delivery, and payer-facing integration. In a fragmented market, that breadth can be valuable where purchasers seek fewer vendor relationships and more coordinated virtual-care capabilities.
American Well (Amwell)
American Well participates primarily as a care-enablement provider, supplying infrastructure that allows health systems, payers, and public-sector organizations to deploy multi-modal virtual-care programs. Its opportunity lies in supporting organizations that want a configurable technology foundation while retaining control over their clinical network and patient experience.
GE Healthcare, Koninklijke Philips N.V., Masimo Corporation, Honeywell International, and AMD Global Telemedicine
These companies contribute through connected monitoring, diagnostic peripherals, virtual-care equipment, clinical command-center capabilities, and supporting infrastructure. Their competitive relevance is linked to the growing importance of device connectivity and actionable patient data in higher-acuity and longitudinal telemedicine models.
Oracle Health, Cisco Systems, Health Catalyst, Veradigm LLC, Updox, Mend, HIPAAVideo.net, and VCDoctor
Enterprise technology and workflow vendors compete through integration, security, communications, data intelligence, and provider usability. Their market role is important because telemedicine programs increasingly depend on compatibility with existing electronic health record, collaboration, and care-coordination environments.
AMC Health, RemetricHealth, SOC Telemed, Eagle Telemedicine, Specialist Telemed, and McKesson Medical-Surgical
These participants address specialized remote monitoring, acute-care coverage, virtual specialty services, and supply-chain support. Their positioning reflects the continued need for purpose-built clinical models and operational expertise within a market that cannot be served solely through general-purpose video technology.
Recent Industry Developments
Teladoc Health
Teladoc Health announced the availability of virtual-care services through Walmart's Better Care Services platform in May 2026. The arrangement expands consumer access to virtual urgent care, dermatology, and nutrition services through a retail-health distribution channel, reinforcing the importance of consumer-facing partnerships in telemedicine growth. [6]Amazon. "An Update on Amazon Health Services Leadership." aboutamazon.com
Amazon Health Services
Amazon announced that Dr. Roy Schoenberg would lead Amazon Health Services effective July 1, 2026. The appointment brings telehealth platform experience into a broader consumer-health portfolio that includes pharmacy, primary care, and health-benefit services, underscoring the strategic value of integrated distribution and technology ecosystems.
Need a specific section of this report?
Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.
Frequently Asked Questions (FAQs):
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Industry journals, trade publications, and specialized media.
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 20+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →